Attainment of Inactive Disease Following Discontinuation of Adalimumab Monotherapy in Patients With Enthesitis-Related Arthritis: A Real-Life, Dual-Center Experience.

Papailiou, Stayroula; Dasoula, Foteini; Tsolia, Maria N; Maritsi, Despoina N

Papailiou, Stayroula; Dasoula, Foteini; Tsolia, Maria N; Maritsi, Despoina N.

Afiliação

Papailiou S; From the Infectious Diseases, Immunology and Rheumatology Unit, Second Department of Paediatrics, "P. & A. Kyriakou" Children's Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Dasoula F; From the Infectious Diseases, Immunology and Rheumatology Unit, Second Department of Paediatrics, "P. & A. Kyriakou" Children's Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Tsolia MN; From the Infectious Diseases, Immunology and Rheumatology Unit, Second Department of Paediatrics, "P. & A. Kyriakou" Children's Hospital, National and Kapodistrian University of Athens, Athens, Greece.

J Clin Rheumatol ; 28(2): e616-e618, 2022 Mar 01.

Article em En | MEDLINE | ID: mdl-34145201

Assuntos

Antirreumáticos; Artrite Juvenil; Adalimumab/uso terapêutico; Antirreumáticos/uso terapêutico; Artrite Juvenil/tratamento farmacológico; Humanos; Resultado do Tratamento

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Juvenil / Antirreumáticos Limite: Humans Idioma: En Revista: J Clin Rheumatol Assunto da revista: FISIOLOGIA / ORTOPEDIA / REUMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Grécia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google